Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
4
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| JACOBSEN MICHAEL A | VP of Finance and PAO | 1 | $0 | $0 | 2012-04-24 |
| Kaye Edward M. MD | SVP & Chief Medical Officer | 1 | $0 | $0 | 2012-04-24 |
| Christopher Nishan Garabedian | President and CEO | 2 | $0 | $0 | 2012-04-24 |
| Price Ben Gil | Director | 1 | $39.0K | $0 | 2012-03-14 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Christopher Nishan Garabedian | President and CEO | A Award deriv | 2012-04-24 | 2012-04-25 | 245,000 | — | $0 | 245,000 | SEC↗ |
| Kaye Edward M. MD | SVP & Chief Medical Officer | A Award deriv | 2012-04-24 | 2012-04-25 | 68,110 | — | $0 | 68,110 | SEC↗ |
| JACOBSEN MICHAEL A | VP of Finance and PAO | A Award deriv | 2012-04-24 | 2012-04-25 | 22,211 | — | $0 | 22,211 | SEC↗ |
| Christopher Nishan Garabedian | President and CEO | A Award | 2012-04-24 | 2012-04-25 | 81,666 | — | $0 | 511,666 | SEC↗ |
| Price Ben Gil | Director | P Buy | 2012-03-14 | 2012-03-15 | 30,000 | $1.30 | $39.0K | 197,982 | SEC↗ |